In contrast, the highest ADCC was detected against cancer lines expressing high levels of CD137L which in combination with the increased expression of CD137 on NK cells after cetuximab stimulation indicates the positive effect of co-stimulatory signals in enhancing ADCC. The gene discussed is TNFRSF9; the disease is cancer.